Original language | English |
---|---|
Pages (from-to) | 410-411 |
Number of pages | 2 |
Journal | The Lancet Oncology |
Volume | 11 |
Issue number | 5 |
Publication status | Published - 1 May 2010 |
The ethical and scientific case for phase 2C clinical trials
Ying-Kiat Zee*, Sarah W. Chan, John Harris, Gordon C. Jayson
*Corresponding author for this work
Research output: Contribution to journal › Editorial